Adherence to antiretroviral therapy in rural persons living with HIV disease in the United States

被引:82
作者
Heckman, BD
Catz, SL
Heckman, TG
Miller, JG
Kalichman, SC
机构
[1] Med Coll Wisconsin, Milwaukee, WI 53226 USA
[2] Univ Connecticut, Storrs, CT 06269 USA
来源
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV | 2004年 / 16卷 / 02期
关键词
D O I
10.1080/09540120410001641066
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The current study delineated patterns and predictors of adherence to antiretroviral therapy in 329 persons living with HIV disease in rural areas of 12 US states. Participants provided self- report data on patterns of HIV medication adherence, reasons for missing medication doses, psychological symptomatology, life- stressor burden, social support, ways of coping, coping self- efficacy, the quality of their relationship with their main physician, and barriers to health care and social services. Based on adherence data collected via retrospective, self- report assessment instruments, only 50% of participants adhered consistently to antiretroviral therapy regimens in the past week. Consistent adherence was more common in White participants, persons who had progressed to AIDS, and ' native infections' ( i. e. persons who were born, raised, and infected in their current place of residence). Logistic regression analyses indicated that consistent adherence was reported by persons who drank less alcohol, had a good relationship with their main physician, and engaged in more active coping in response to HIV- related life stressors. As the number of rural persons living with HIV disease continues to increase, research that identifies correlates of non- adherence and conceptualizes approaches to optimize adherence in this group is urgently needed.
引用
收藏
页码:219 / 230
页数:12
相关论文
共 37 条
[1]  
[Anonymous], 1988, MANUAL WAYS COPING Q
[2]   Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population [J].
Bangsberg, DR ;
Hecht, FM ;
Charlebois, ED ;
Zolopa, AR ;
Holodniy, M ;
Sheiner, L ;
Bamberger, JD ;
Chesney, MA ;
Moss, A .
AIDS, 2000, 14 (04) :357-366
[3]  
Beck A.T., 1993, BECK DEPRESSION INVE
[4]  
Berry DE, 1996, AIDS PUBLIC POLICY J, V11, P36
[5]   Protease inhibitor use among a community sample of people with HIV disease [J].
Bing, EG ;
Kilbourne, AM ;
Brooks, RA ;
Lazarus, EF ;
Senak, M .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1999, 20 (05) :474-480
[6]   Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease [J].
Catz, SL ;
Kelly, JA ;
Bogart, LM ;
Benotsch, EG ;
McAuliffe, TL .
HEALTH PSYCHOLOGY, 2000, 19 (02) :124-133
[7]  
Catz SL., 2001, Psychol Health Med, V6, P47, DOI DOI 10.1080/13548500020021919
[8]  
*CDCP, 2001, HIV AIDS SURVEILLANC, V13, P11
[9]  
*CDCP, 1999, HIB AIDS SURVEILLA S, V5, P8
[10]   Development and validation of the functional assessment of human immunodeficiency virus infection (FAHI) quality of life instrument [J].
Cella, DF ;
McCain, NL ;
Peterman, AH ;
Mo, F ;
Wolen, D .
QUALITY OF LIFE RESEARCH, 1996, 5 (04) :450-463